View source for Fixed dose combination (antiretroviral)

'''Fixed dose combinations''' of [[antiretroviral drug|antiretrovirals]] are multiple antiretroviral drugs combined into a single pill, which helps reduce [[pill burden]]. They may combine different classes of antiretrovirals or contain only a single class. Licensed fixed dose combinations are shown in the table below.
                                                                      
{| class="wikitable"
! Brand Name !! Drug Names ([[INN]]) !! Date of FDA Approval !! Company
|-
| [[Combivir]]&reg; || [[zidovudine]] + [[lamivudine]] || [[September 26]], [[1997]] || [[GlaxoSmithKline]]
|-
| [[Trizivir]]&reg; || [[abacavir]] + [[zidovudine]] + [[lamivudine]] || [[November 15]], [[2000]]  || [[GlaxoSmithKline]]
|-
| [[Lopinavir|Kaletra]]&reg; || [[lopinavir]] + [[ritonavir]] || [[September 15]], [[2000]] || [[Abbott Laboratories]]
|-
| [[Epzicom]]&reg; (in USA)<br />[[Kivexa]]&reg; (in Europe) ||  [[abacavir]] + [[lamivudine]] || [[August 2]], [[2004]]  || [[GlaxoSmithKline]]
|-
| [[Truvada]]&reg; || [[emtricitabine]] + [[tenofovir]] || [[August 2]], [[2004]] || [[Gilead Sciences]]
|-
| [[Atripla]]&reg; || [[efavirenz]] + [[emtricitabine]] + [[tenofovir]] || [[July 12]], [[2006]] || [[Gilead Sciences]] and <br />[[Bristol-Myers Squibb]]
|}

==See also==
*[[Fixed dose combination]]
*[[Pill burden]]

{{Antivirals}}

[[Category:Antiretroviral drugs]]
{{WikiDoc Sources}}